Adverum Biotechnologies, Inc.

ADVM

Adverum Biotechnologies, Inc.

ADVM

Insider Sentiment (TTM):

Last Purchase:2025-12-08Last Sale:2025-12-04Shares Purchased (TTM):167,614Shares Sold (TTM):747,485

Institutional Sentiment:

As of:2025-09-30Institutional Shares Owned:11,488,922Shares Outstanding:23,487,000Institutional Ownership Pct.:48.92%

Earnings Market Reaction:

Filing Date:2025-11-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Biological Products, (No Diagnostic Substances)

AMGN GILD SCLX BIIB MRNA RVMD

Adverum Biotechnologies, Inc. (ADVM) — SEC Financial Statements & Analysis

Adverum Biotechnologies, Inc. (ADVM) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	26	42	49	61	93	127	150	75	105	111	68	68
Short Term Investments	0	2	34	65	60	47	44	22	12	30	97	117
Prepaid Expense And Other Assets Current	3	4	6	6	8	6	6	6	8	6	5	5
Incentive To Lessee	-	-	-	-	-	-	-	-	-	-	-	0
Assets Current	29	48	89	131	161	179	199	103	125	147	169	191
Operating Lease Right Of Use Asset	29	34	34	34	51	51	52	35	53	58	70	79
Property Plant And Equipment Net	10	11	11	12	12	13	14	15	15	32	33	35
Deferred Rent Receivables Net	-	-	-	-	7	7	-	-	-	-	-	0
Restricted Cash Noncurrent	2	2	2	2	2	2	2	2	3	3	3	3
Other Assets Noncurrent	2	1	1	1	1	1	1	1	1	1	1	1
Assets	72	96	138	180	234	254	268	156	197	241	276	308
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	12	5	2	2	2	2	2	2	2	1	3	2
Operating Lease Liability Current	6	7	7	6	11	11	10	5	10	25	26	13
Liabilities Current	45	31	25	23	28	22	22	20	29	45	46	32
Liabilities Noncurrent
Operating Lease Liability Noncurrent	83	85	86	86	63	63	64	69	65	66	71	94
Other Liabilities Noncurrent	0	0	0	0	-	-	-	0	0	0	0	1
Liabilities	128	116	111	109	90	86	86	89	94	110	118	127
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,156	1,143	1,141	1,138	1,135	1,132	1,127	1,004	999	995	990	986
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-1	-1	-0	-1	-1	-1	-2
Retained Earnings Accumulated Deficit	-1,211	-1,163	-1,114	-1,067	-990	-963	-945	-936	-896	-863	-832	-803
Stockholders Equity	-56	-20	26	71	108	137	164	67	103	131	158	182
Liabilities And Stockholders Equity	72	96	138	180	234	254	268	156	197	241	276	308
Common Stock Shares Issued	-	-	-	104	-	-	-	101	-	-	-	100
Shares Outstanding	-	-	-	21	-	-	-	10	-	-	-	10
Common Stock Shares Authorized	-	-	-	300	-	-	-	300	-	-	-	300
Common Stock Par Or Stated Value Per Share	-	-	-	0	-	-	-	0	-	-	-	0
Preferred Stock Par Or Stated Value Per Share	-	-	-	0	-	-	-	0	-	-	-	0
Preferred Stock Shares Authorized	-	-	-	5	-	-	-	5	-	-	-	5
Preferred Stock Shares Issued	-	-	-	0	-	-	-	0	-	-	-	0
Preferred Stock Shares Outstanding	-	-	-	0	-	-	-	0	-	-	-	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	37.38%	10.68%	12.62%	42.51%	118.22%	74.09%	-0.93%	-	-	-	-	-
2024	-17.59%	-28.62%	-14.98%	4.16%	16.02%	14.18%	-11.94%	-36.34%	-40.45%	-13.00%	-12.38%	-29.41%
2023	44.05%	89.29%	147.62%	-1.64%	-18.03%	-48.09%	-9.07%	-17.27%	3.24%	-33.73%	-47.46%	-58.47%
2022	-	-	-	-	-	-	-	-	-	29.17%	14.86%	111.11%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	0.65	1.54	3.57	5.73	5.82	7.99	9.24	5.14	4.32	3.31	3.63	5.91
Quick Ratio	0.58	1.42	3.31	5.49	5.54	7.74	8.97	4.83	4.06	3.18	3.54	5.76
Working Capital	-15.84M	17.04M	64.38M	108.40M	133.42M	156.96M	177.58M	82.79M	95.74M	102.63M	122.40M	158.35M
Leverage & Debt
Debt to Equity	-2.30	-5.76	4.21	1.54	0.83	0.62	0.52	1.32	0.92	0.84	0.75	0.70
Debt Ratio	1.77	1.21	0.81	0.61	0.39	0.34	0.32	0.57	0.48	0.46	0.43	0.41
Efficiency & Turnover
Asset Turnover TTM	0.00	0.01	0.00	0.01	0.00	0.00	0.00	0.02	0.01	0.01	0.01	0.00
Per Share Metrics
Diluted EPS TTM	-7.87	-8.07	-7.20	-6.62	-5.68	-5.72	-7.29	-12.11	-12.49	-13.24	-14.52	-15.57
Free Cash Flow Per Share TTM	-5.89	-6.26	-5.37	-4.69	-4.12	-4.27	-5.62	-9.10	-8.80	-9.63	-10.88	-12.08
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-17,513.20%	-15,818.10%	-13,915.90%	-12,765.00%	-	-	-3,581.72%	-3,660.36%	-3,841.14%	-4,145.58%	-
Net Profit Margin TTM	-	-16,949.20%	-15,079.90%	-13,092.70%	-11,866.10%	-	-	-3,392.11%	-3,505.19%	-3,706.47%	-4,046.78%	-
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	-	-	-72.22%	-72.22%	-100.00%	-100.00%	-	-	-	-	-100.00%
Net Income Growth (1Y)	55.73%	42.20%	25.45%	7.22%	-5.96%	-10.67%	-17.49%	-20.98%	-19.22%	-13.60%	-6.02%	6.18%
EPS Growth (1Y)	38.42%	41.13%	-1.27%	-45.36%	-54.50%	-56.83%	-49.78%	-22.21%	-20.44%	-15.12%	-7.61%	4.88%
Calculated Values
Free Cash Flow TTM	-138.45M	-131.53M	-112.51M	-92.85M	-86.06M	-89.12M	-92.55M	-91.71M	-88.85M	-97.07M	-109.10M	-119.91M
Net Debt	-28.04M	-44.39M	-49.16M	-62.63M	-92.85M	-127.32M	-151.58M	-75.00M	-108.02M	-111.19M	-67.55M	-70.93M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-08Purchase

Owner: Fischer, Laurent

Title: CEO, PRESIDENT AND DIRECTOR

Shares: 117,614

Price/Share: $4.31

Value: $506,916.34

Shares Owned: 201,513

Relationship: Director,Officer

Ownership: Direct

2025-12-05Purchase

Owner: Soparkar, Peter

Title: CHIEF OPERATING OFFICER

Shares: 50,000

Price/Share: $4.22

Value: $211,000.00

Shares Owned: 80,189

Relationship: Officer

Ownership: Direct

2025-12-04Sale

Owner: Leonard, Braden Michael

Title: -

Shares: 524,560

Price/Share: $4.19

Value: $2,197,906.40

Shares Owned: 1,958,080

Relationship: TenPercentOwner

Ownership: Indirect

2025-12-03Sale

Owner: Leonard, Braden Michael

Title: -

Shares: 222,925

Price/Share: $4.17

Value: $929,597.25

Shares Owned: 2,428,640

Relationship: TenPercentOwner

Ownership: Indirect

2025-05-15Sale

Owner: Fischer, Laurent

Title: CEO, PRESIDENT AND DIRECTOR

Shares: 9,126

Price/Share: $2.00

Value: $18,252.00

Shares Owned: 87,488

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-08	Fischer, Laurent	Director,Officer	CEO, PRESIDENT AND DIRECTOR	Direct	Purchase	117,614	4.31	$506,916.34	201,513	4
2025-12-05	Soparkar, Peter	Officer	CHIEF OPERATING OFFICER	Direct	Purchase	50,000	4.22	$211,000.00	80,189	4
2025-12-04	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Sale	524,560	4.19	$2,197,906.40	1,958,080	4
2025-12-03	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Sale	222,925	4.17	$929,597.25	2,428,640	4
2025-05-15	Fischer, Laurent	Director,Officer	CEO, PRESIDENT AND DIRECTOR	Direct	Sale	9,126	2.00	$18,252.00	87,488	4
2025-05-15	Soparkar, Peter	Officer	CHIEF OPERATING OFFICER	Direct	Sale	2,960	2.00	$5,920.00	39,154	4
2025-05-15	Seyedkazemi, Setareh	Officer	CHIEF DEVELOPMENT OFFICER	Direct	Sale	924	2.00	$1,848.00	13,768	4
2025-04-23	Leonard, Braden Michael	TenPercentOwner	-	Direct	Purchase	50,000	2.98	$149,000.00	191,800	4
2025-04-02	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	15,209	4.04	$61,444.36	2,757,526	4
2025-03-27	Leonard, Braden Michael	TenPercentOwner	-	Direct	Purchase	16,593	5.19	$86,117.67	141,800	4/A
2025-03-27	Leonard, Braden Michael	TenPercentOwner	-	Direct	Purchase	16,593	5.19	$86,117.67	141,800	4
2025-03-20	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	30,600	5.61	$171,666.00	2,722,761	4
2025-02-28	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	85,068	4.60	$391,312.80	2,604,820	4
2024-07-30	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	85,800	7.15	$613,470.00	2,268,064	4
2024-07-18	Leonard, Braden Michael	TenPercentOwner	-	Indirect	Purchase	80,718	9.11	$735,340.98	2,182,264	4
2024-02-07	Lupher,, Jr. Mark L.	Director	-	Direct	Purchase	130,000	1.35	$175,500.00	130,000	4
2024-02-07	Scopa, James Paul	Director	-	Direct	Purchase	100,000	1.35	$135,000.00	100,000	4
2023-09-15	Seyedkazemi, Setareh	Officer	Chief Development Officer	Direct	Sale	6,201	1.54	$9,549.54	47,674	4
2023-06-07	Rubinstein, Linda M	Officer	Chief Financial Officer	Direct	Purchase	100,000	1.45	$145,000.00	100,000	4
2023-03-15	Fischer, Laurent	Director,Officer	CEO, President and Director	Direct	Sale	41,239	0.78	$32,166.42	692,141	4
2023-03-15	Riley, Brigit	Officer	Chief Scientific Officer	Direct	Sale	7,299	0.78	$5,693.22	117,435	4
2023-03-15	Soparkar, Peter	Officer	Chief Operating Officer	Direct	Sale	13,360	0.78	$10,420.80	265,891	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-09-30

48.92%

Inst. Shares: 11,488,922

Shares Outstanding: 23,487,000

2025-06-30

64.11%

Inst. Shares: 13,469,160

Shares Outstanding: 21,010,000

2025-03-31

75.42%

Inst. Shares: 15,791,039

Shares Outstanding: 20,938,000

2024-12-31

70.73%

Inst. Shares: 13,991,116

Shares Outstanding: 19,782,000

2024-09-30

78.36%

Inst. Shares: 16,358,910

Shares Outstanding: 20,876,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-09-30	11,488,922	23,487,000	48.92%
2025-06-30	13,469,160	21,010,000	64.11%
2025-03-31	15,791,039	20,938,000	75.42%
2024-12-31	13,991,116	19,782,000	70.73%
2024-09-30	16,358,910	20,876,000	78.36%
2024-06-30	15,198,916	20,852,000	72.89%
2024-03-31	12,853,959	16,479,000	78.00%
2023-12-31	62,304,063	10,082,000	-
2023-09-30	63,912,434	10,100,000	-
2023-06-30	64,291,726	10,077,000	-
2023-03-31	60,020,001	10,030,000	-
2022-12-31	50,896,939	9,925,100	-
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Adverum Biotechnologies, Inc. (ADVM) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.